| Decipher Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524752 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE643N01012 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 8.34 |
Market Cap(₹Cr) : 7.85 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.13 | 0.09 | 0.85 | 0.23 | 0.16 | 0.08 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.13 | 0.09 | 0.85 | 0.23 | 0.16 | 0.08 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Total Income | 0.13 | 0.09 | 0.85 | 0.23 | 0.16 | 0.10 |
| Total Expenditure | 0.14 | 0.20 | 0.78 | 0.39 | 0.25 | 0.15 |
| PBIDT | 0.00 | -0.11 | 0.06 | -0.16 | -0.09 | -0.05 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.00 | -0.11 | 0.06 | -0.16 | -0.09 | -0.05 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.01 | -0.12 | 0.06 | -0.17 | -0.09 | -0.06 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.01 | -0.12 | 0.06 | -0.17 | -0.09 | -0.06 |
| EPS (Unit Curr.) | -0.01 | -0.11 | 0.06 | -0.17 | -0.09 | -0.06 |
| EPS (Adj) (Unit Curr.) | -0.01 | -0.11 | 0.06 | -0.17 | -0.09 | -0.06 |
| Calculated EPS (Unit Curr.) | -0.01 | -0.11 | 0.06 | -0.17 | -0.09 | -0.06 |
| Calculated EPS (Adj) (Unit Curr.) | -0.01 | -0.11 | 0.06 | -0.17 | -0.09 | -0.06 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.06 | -0.46 | 0.22 | -0.67 | -0.36 | -0.22 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.06 | -0.46 | 0.22 | -0.67 | -0.36 | -0.22 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | -122.22 | 7.06 | -69.57 | -56.25 | -62.50 |
| PBDTM(%) | 0.00 | -122.22 | 7.06 | -69.57 | -56.25 | -62.50 |
| PATM(%) | -7.69 | -133.33 | 7.06 | -73.91 | -56.25 | -75.00 |
